IDEXX Laboratories Inc. (Nasdaq: IDXX), the Westbrook maker of veterinary diagnostics, veterinary software and water testing, on Wednesday posted lower first-quarter earnings than a year ago and cut its outlook for 2022 due to the strengthening U.S. dollar, higher interest rates and the war in Ukraine.

Quarterly earnings totaled $193.9 million, or $2.27 a share, down from $204.3 million, or $2.35 a share, for the same period in 2021. The results, while lower, still surpassed Wall Street expectations of $2.25 a share, according to Zacks Investment Research. Read more